SAB Biotherapeutics Inc (NAS:SABSW)
$ 0.036 (0%) Market Cap: 0 Enterprise Value: 0 PE Ratio: 9,999.00 PB Ratio: 0 GF Score: 26/100

SAB Biotherapeutics Inc at Citi Biopharma Back to School Summit Transcript

Sep 10, 2026 / 03:20 PM GMT
Release Date Price: $0.0358


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

SABS.OQ - SAB Biotherapeutics, Inc.
SAB Biotherapeutics Inc at Citi Biopharma Back to School Summit
Sep 10, 2026 / 03:20PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning. I am Sam Semenka. I'm one of the senior biotech analysts here at Citi, and it is my pleasure to be hosting SAB Bio at Citi's 2026 BioPharma Back to School Summit. I'm joined by Sam Reich, CEO, and Lucy To, CFO of SAB Bio.

Sam, Lucy, welcome, and thank you so much for being here.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you for having us. It's a pleasure.

--------------------------------------------------------------------------------
Unidentified_1 [3]
-------------------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot